Director of clinical effectiveness and operations at Prime Therapeutics LLC. Prime Therapeutics is a pharmacy benefits manager owned by 19 Blue Cross and Blue Shield plans.
I grew up in North Dakota. My parents are small-business owners, and working alongside them was an important early influence. Although I may not have recognized it at the time, I was learning valuable skills by observing how well they treated both those they worked with and their customers — lessons I have used throughout my career. I graduated from North Dakota State University with a Doctor of Pharmacy degree and worked in a retail setting prior to moving to managed care. Today, my team works with internal and external partners to strategize and operationalize patient outreach programs to improve medication outcomes and generate cost savings for our members and health plans.
In one of my initial roles as a retail pharmacist, I was able to offer medication therapy management (MTM) services through a pilot program. The extended interactions I had with my patients were a small but meaningful and fulfilling part of my job, which led me to pursue a role at Prime as an MTM pharmacist. This role positioned me for leadership opportunities and the ability to work cross-functionally with many different teams within the organization. Taking part in a managed care pilot program was a turning point and has shaped my career in ways I did not anticipate.
Working largely in government programs, the ever-changing regulatory landscape brings both short- and long-term challenges that require coordination of many different business areas. It can be challenging to process and identify my team’s role or potential role within a regulatory change to understand how it may require us to reprioritize current or future work.
Aligning with our enterprise priorities, my team will continue to enhance our foundational capabilities and work cross-functionally with internal teams to develop new member and provider outreach programs.
There are many barriers to equitable healthcare access, with both socioeconomic and geographical factors playing a role. If I were able to change one thing, it would be more effective health education regarding navigation of the overall healthcare system and improved communication about benefits and community resources available to individuals in need.
I recommend “Radical Candor” by Kim Scott. The book provides insight into how effective teams are built around the ability for team members and leaders to have kind but open communication. It highlights how effective leaders seek feedback, show vulnerability and create environments where their teams are comfortable sharing their perspectives.
Living in the Midwest, our summers are short, and I try to spend as much time on the water as possible. This summer, I look forward to learning to wakesurf.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Women PCPs Have Equal or Better Medicare Patient Outcomes Than Men PCPs in Value-Based Care Model
June 24th 2025Women primary care providers (PCPs) treating Medicare patients in a value-based care model achieved better patient outcomes and earned more per patient than male counterparts, despite receiving equal patient satisfaction ratings, highlighting a potential for value-based payment to help close the gender pay gap.
Read More
A Progress Report on Chronic GVHD. The Grades Are Not So Great
June 24th 2025There has been no or some progress in most areas since a National Institute of Health consensus development project in 2020, according to a group of experts. But exception is important: Prevention of moderate or severe chronic graft-vs.-host disease.
Read More